RET and neoplasm: Although outside of the scope of this review, RET fusions have also been identified in ~20% of papillary thyroid carcinomas (17, 18), and at a lower frequency (≤1%) in other tumor types including breast (19), colorectal (20), and pancreatic (21) cancers.